Yahoo Web Search

Search results

1. • Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031

     Morningstar· 4 days ago

     FN Media Group News Commentary - The emergence of SARS-CoV-2, which triggered the COVID-19 pandemic with overall is widely regarded as the greatest medical emergency of the ...

2. • 

     Monoclonal Antibody Shows Promise Against Multiple COVID-19 Variants

     Technology Networks· 2 days ago

     A monoclonal antibody appears effective at neutralizing the numerous variants of SARS-CoV-2, as well...

3. • Sunshine Biopharma reports potential SARS-CoV-2 treatment By Investing.com

     Investing.com· 4 days ago

     Sunshine Biopharma, Inc. (NASDAQ:SBFM), a pharmaceutical company, has announced the publication of research highlighting a new antiviral compound, XR8-23 (Compound 10), which targets the < ...

4. • New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market...

     Morningstar· 4 days ago

     FN Media Group News Commentary - The SARS-CoV-2, literally affected the whole world in these past years and has increased a global search for therapies and treatments. Demand ...

5. • ... Positive Opinion Recommending Authorization of Moderna’s COVID-19 mRNA Vaccine Targeting the ...

     Miami Herald· 3 days ago

     Moderna’s updated COVID-19 mRNA vaccine will be available for the 2024-2025 vaccination season, pending a European Commission authorization decision

6. • 

     What does it mean to have COVID-19 in 2024? What to know amid increase in cases

     Gannett via AOL· 5 days ago

     What is the difference between COVID-19 and the flu? While both are respiratory illnesses with...

7. • 

     Immune Pathway Linked to Long COVID Lung Scarring Discovered

     Technology Networks· 4 days ago

     Study identifies CD8+ T cells as a key factor preventing lung healing after viral infections like...

8. • 

     Antibody Discovery Offers New Hope in the Search for a Universal COVID-19 Vaccine

     Technology Networks· 3 days ago

     Researchers have discovered an antibody able to neutralize all known variants of SARS-CoV-2, the...

9. • Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhuman...

     Nature· 5 days ago

     Seder and colleagues show that mucosal adenoviral-vectored vaccine boosting durably prevents infection in nonhuman primates of the highly transmissible, heterologous XBB.1.16 strain of SARS-CoV-2.

10. • Sunshine Biopharma Announces Publication of Significant Coronavirus Research Results in the Journal...

      Digital Journal· 4 days ago

      (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced the ...